A retrospective analysis of glucose intolerance in individuals with liver cirrhosis
DOI:
https://doi.org/10.56294/hl2025616Keywords:
Diabetes mellitus (DM), Impaired glucose tolerance (IGT), oral glucose tolerance test(OGTT), Patients, liver cirrhosisAbstract
The prediction of liver cirrhosis can be affected by diabetes mellitus (DM), a worldwide health issue that can impair the body's metabolic processes. Patients with liver cirrhosis benefit from knowing their glycemic status that problems can be anticipated and treated sooner, improving their prognosis. Impaired glucose tolerance (IGT) can be understated utilizing standard approaches. The research utilized an oral glucose tolerance test (OGTT) to recognize the popularity of IGT in individuals with liver cirrhosis who are not diagnosed with diabetes. The dataset for the research would include individuals diagnosed with liver cirrhosis who have not been diagnosed with diabetes mellitus. It would encompass demographic details (N=80) such as age, gender, and medical history, along with liver function parameters including liver enzymes, bilirubin, and albumin levels. Statistical analysis was conducted using IBM SPSS Statistics (Version 26.0) software. Independent t-tests were applied to compare continuous variables, while chi-square tests were used to analyze categorical variables. The frequency of IGT in the research was 36.47 percent. In addition to IGT, observed that DM was more frequent in those aged 31-40; of the 80 patients analyzed in research, 24.71 percent were diagnosed with DM. OGTT can improve liver cirrhosis prognosis by detecting diabetes and insulin resistance in patients, potentially reducing the risk of complications due to poor glucose management.
References
1. Sera N, Nakamura T, Horie I, Higashi R, Tominaga R, Yamamoto H, Nozaki A, Natsuda S, Takashima H, Kamada A, Abiru N. Characteristics of patients who developed glucose intolerance in the early period after partial pancreatectomy. Diabetology international. 2021 Jan;12:140-4.https://doi.org/10.1007/s13340-020-00440-y
2. De Sanctis V, SolimanAT, Tzoulis P, Daar S, Di Maio S, Fiscina B, Kattamis C. Glucose metabolism and insulin response to oral glucose tolerance test (OGTT) in prepubertal patients with transfusion-dependent β-thalassemia (TDT): A long-term retrospective analysis. Mediterranean Journal of Hematology and Infectious Diseases. 2021 Sep 1;13(1): e2021051.https://doi.org/10.4084/MJHID.2021.051
3. Xiao Y, Zhang X. Association between maternal glucose/lipid metabolism parameters and abnormal newborn birth weight in gestational diabetes complicated by preeclampsia: a retrospective analysis of 248 cases. Diabetes Therapy. 2020 Apr; 11:905-14.https://doi.org/10.1007/s13300-020-00792-3
4. Miyake T, Matsuura B, Furukawa S, Yoshida O, Hirooka M, Kumagi T, Ishihara T, Kanzaki S, Nakaguchi H, Miyazaki M, Nakamura Y. Nonalcoholic fatty liver disease is a risk factor for glucose intolerance onset in men regardless of alanine aminotransferase status. Journal of Diabetes Investigation. 2021 Oct;12(10):1890-8.https://doi.org/10.1111/jdi.13548
5. Merkofer F, Struja T, Delfs N, Spagnuolo CC, Hafner JF, Kupferschmid K, Baechli C, Schuetz P, Mueller B, Blum CA. Glucose control after glucocorticoid administration in hospitalized patients–a retrospective analysis. BMC Endocrine Disorders. 2022 Dec;22:1-8.https://doi.org/10.1186/s12902-021-00914-3
6. Delfs N, Struja T, Gafner S, Muri T, Baechli C, Schuetz P, Mueller B, Blum CA. Outcomes of hospitalized patients with glucocorticoid-induced hyperglycemia—a retrospective analysis. Journal of clinical medicine. 2020 Dec 17;9(12):4079.https://doi.org/10.3390/jcm9124079
7. Wang X, Li J, Huo L, Feng Y, Ren L, Yao X, Jiang H, Lv R, Zhu M, Chen J. Clinical characteristics of diabetic nephropathy in patients with type 2 diabetic mellitus manifesting heavy proteinuria: a retrospective analysis of 220 cases. Diabetes Research and Clinical Practice. 2019 Nov 1;157:107874.https://doi.org/10.1016/j.diabres.2019.107874
8. Ahrén B, Pacini G. Glucose effectiveness: Lessons from studies on insulin‐independent glucose clearance in mice. Journal of diabetes investigation. 2021 May;12(5):675-85.https://doi.org/10.1111/jdi.13446
9. Stahl K, Busch M, Maschke SK, Schneider A, Manns MP, Fuge J, Wiesner O, Meyer BC, Hoeper MM, Hinrichs JB, David S. A retrospective analysis of nonocclusive mesenteric ischemia in medical and surgical ICU patients: clinical data on demography, clinical signs, and survival. Journal of Intensive Care Medicine. 2020 Nov;35(11):1162-72.https://doi.org/10.1177/0885066619837911
10. Tommerdahl KL, Brinton JT, Vigers T, Cree-Green M, Zeitler PS, Nadeau KJ, Chan CL. Delayed glucose peak and elevated 1-hour glucose on the oral glucose tolerance test identify youth with cystic fibrosis with lower oral disposition index. Journal of Cystic Fibrosis. 2021 Mar 1;20(2):339-45.https://doi.org/10.1016/j.jcf.2020.08.020
11. Yang MM, Wang L, Zhang Y, Yuan R, Zhao Y, Hu J, Zhou FH, Kang HJ. Establishment and effectiveness evaluation of a scoring system for exertional heat stroke by retrospective analysis. Military medical research. 2020 Dec;7:1-4.https://doi.org/10.1186/s40779-020-00269-1
12. Kaneko H, Itoh H, Kiriyama H, Kamon T, Fujiu K, Morita K, Michihata N, Jo T, Takeda N, Morita H, Yasunaga H. Fasting plasma glucose and subsequent cardiovascular disease among young adults: analysis of a nationwide epidemiological database. Atherosclerosis. 2021 Feb 1;319:35-41.https://doi.org/10.1016/j.atherosclerosis.2020.12.024
13. Lo JC, Twan DC, Karamchedu S, Lee XK, Ong JL, Van Rijn E, Gooley JJ, Chee MW. Differential effects of split and continuous sleep on neurobehavioral function and glucose tolerance in sleep-restricted adolescents. Sleep. 2019 May;42(5):zsz037.https://doi.org/10.1093/sleep/zsz037
14. Markus MR, Rospleszcz S, Ittermann T, Baumeister SE, Schipf S, Siewert-Markus U, Lorbeer R, Storz C, Ptushkina V, Peters A, Meisinger C. Glucose and insulin levels are associated with arterial stiffness and concentric remodeling of the heart. Cardiovascular diabetology. 2019 Dec;18:1-6.https://doi.org/10.1186/s12933-019-0948-4
15. Wang Y, Lipner SR. Retrospective analysis of adverse events with systemic onychomycosis medications reported to the United States Food and Drug Administration. Journal of Dermatological Treatment. 2021 Oct 3;32(7):783-7.https://doi.org/10.1080/09546634.2019.1708242
16. Fehily SR, Papaluca T, Thompson AJ. Long-term impact of direct-acting antiviral agent therapy in HCV cirrhosis: critical review. InSeminars in liver disease 2019 Jul (Vol. 39, No. 03, pp. 341-353). Thieme Medical Publishers.DOI: 10.1055/s-0039-1685538
17. Teo SY, Kanaley JA, Guelfi KJ, Marston KJ, Fairchild TJ. The impact of exercise timing on glycemic control: a randomized clinical trial. Medicine and science in sports and exercise. 2020 Feb 1;52(2):323-34.https://doi.org/10.1249/MSS.0000000000002139
18. Hassan N, Anesio AM, Rafiq M, Holtvoeth J, Bull I, Haleem A, Shah AA, Hasan F. Temperature driven membrane lipid adaptation in glacial psychrophilic bacteria. Frontiers in Microbiology. 2020 May 14;11:824.https://doi.org/10.3389/fmicb.2020.00824
19. Hoyer SI. Abnormalities of glucose metabolism in Alzheimer's disease. Annals of the New York Academy of Sciences. 1991 Jan 1;640:53-8.DOI: 10.1111/j.1749-6632. 1991.tb00190.x
20. Hino K, Nishina S, Sasaki K, Hara Y. Mitochondrial damage and iron metabolic dysregulation in hepatitis C virus infection. Free Radical Biology and Medicine. 2019 Mar 1;133:193-9.https://doi.org/10.1016/j.freeradbiomed.2018.09.044
21. Shinohara M, Suzuki K, Bu G, Sato N. Interaction between APOE genotype and diabetes in longevity. Journal of Alzheimer’s Disease. 2021 Jul 21;82(2):719-26.https://doi.org/10.3233/JAD-210125
22. Danne T, Garg S, Peters AL, Buse JB, Mathieu C, Pettus JH, Alexander CM, Battelino T, Ampudia-Blasco FJ, Bode BW, Cariou B. International consensus on risk management of diabetic ketoacidosis in patients with type 1 diabetes treated with sodium–glucose cotransporter (SGLT) inhibitors. Diabetes care. 2019 Jun 1;42(6):1147-54.https://doi.org/10.2337/dc18-2316
23. Jackson K, Johnston R, Mackay L, Aujayeb A. A difficult pleural effusion in a cirrhotic patient. Breathe. 2020 Jun;16(2):200049.https://doi.org/10.1183/20734735.0049-2020
24. Diab J, O’Hara J, Pye M, Parker C, Maitz PK, Issler-Fisher A. Foot burns: a comparative analysis of diabetic and non-diabetic patients. Burns. 2021 May 1;47(3):705-13.https://doi.org/10.1016/j.burns.2020.07.024
25. Morimoto A, Kadoya M, Kakutani-Hatayama M, Kosaka-Hamamoto K, Miyoshi A, Shoji T, Goda A, Asakura M, Koyama H. Subclinical decrease in cardiac autonomic and diastolic function in patients with metabolic disorders: HSCAA study. Metabolism Open. 2020 Mar 1; 5:100025.https://doi.org/10.1016/j.metop.2020.100025.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Bamalakshmi J, Siddharth Sriram, Anees Fathima Thabassum Z, Rapaka Sudhir, Yuvraj Parmar, Chhaya Agarwal (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
